Global

In this second conversation of the “World We Want” podcast series, RELX’s Global Head of Corporate Responsibility, Dr Márcia Balisciano, talks to Mary Robinson about leadership.
Elsevier,

Sex Differences in Cardiac Diseases, Elsevier, 2021, Pages 481-503

This book chapter advances SDG 3 and 5 by explaining how women have an increased risk of certain chronic autoimmune inflammatory disorders (CIDs). All aspects of the heart’s structure and function may be affected by the autoimmune disease.
Elsevier,

Sex Differences in Cardiac Diseases, Elsevier, 2021, Pages 671-687

This book chapter addresses SDG 3 and 5 by describing specialized cardiovascular care for women, delivered in “women’s heart programs” (WHPs) focus on the cardiovascular needs of women. This chapter reviews the historical background leading to their development, their structure and specialized areas of focus including referral criteria for unique cardiovascular disease (CVD) risk factors in women, and CVD disorders resulting in acute coronary syndromes (ACS) with pathophysiologies seen exclusively, and/or more commonly in women.
This book chapter advances SDG 3 by explaining how sex steroids (hormones), through their interactions with the sex steroid receptors present in the heart and vasculature, and their metabolic effects, play a vital role in cardiovascular (CV) health.
This book chapter advances SDG 3 by explaining how peripartum cardiomyopathy (PPCM) is a significant cause of pregnancy-associated morbidity and mortality.
This book chapter advances SDG 3 by explaining how there are many strategies that have been implemented to increase the transplant donor pool, yet the gap between the demand and the offer remains too wide and, as a consequence, the number of patients dying on the waiting list keeps rising.
This book chapter advances SDG 3 by explaining how many scientists share the conviction that human stem cell technology and greater understanding of stem cell biology will in the coming decades fulfill much of its promise and revolutionise medicine as we know it today, improving patient care without past precedent.
This book chapter advances SDG 3 by explaining how the role of biotechnology as a forerunner in the pathway of revolution of human lives has been promising in the recent past. The achievements of biotechnology in the bio-medical front encompass various products like novel vaccines, diagnostic devices, and novel therapeutic strategies.
Elsevier,

Food, Medical, and Environmental Applications of Polysaccharides, 2021, Pages 381-400

This chapter advances SDGs 3 and 11 by covering the latest advances in biosensors, which play an innovative role in biomedical applications and improving healthcare. Additionally, the focus is on biosensors derived from natural polysaccharides, i.e. sustainable, bio-based materials.
Elsevier,

Gemma C. Cotton, Natalie R. Lagesse, Liam S. Parke, Carla J. Meledandri, 3.04 - Antibacterial Nanoparticles, Editor(s): David L. Andrews, Robert H. Lipson, Thomas Nann, Comprehensive Nanoscience and Nanotechnology (Second Edition), Academic Press, 2019, Pages 65-82

This chapter advances SDGs 3 and 6 by showing how increasing bacterial resistance to commonly used antibiotics is a pressing threat to the human population on a global scale. As the development of new combative drugs is complex, expensive, time consuming and risky, there has been a strong focus in recent years to develop alternative strategies for the treatment of bacterial infections, and nanoscale materials have emerged a strong contender for this purpose.

Pages